Entero Therapeutics, Inc. Gains 36.96%

Fri, Sep 12, 2025 at 07:30 PM

Entero Therapeutics, Inc. (ENTO:NASDAQ) jumped higher at $3.15, a gain of 37%. On Fri, Sep 12, 2025, ENTO:NASDAQ hit a New 2-Week High of $3.15. The stock appeared on our News Catalysts scanner on Thu, Aug 14, 2025 at 11:45 AM in the 'SPLIT' category. From Fri, Aug 29, 2025, the stock recorded 55.56% Up Days and 50.00% Green Days

About Entero Therapeutics, Inc. (ENTO:NASDAQ)

First Wave BioPharma Inc is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases.

Top 10 Gainers:

GlucoTrack, Inc. (GCTK:NASDAQ), 117.45%
HCW Biologics Inc. (HCWB:NASDAQ), 68.37%
Vestand Inc Cl A (New) (VSTD:NASDAQ), 65.12%
Allied Gaming & Entertainment Inc. (AGAE:NASDAQ), 62.44%
Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 48.99%
Envirotech Vehicles, Inc. (EVTV:NASDAQ), 48.91%
Huize Holding Limited (HUIZ:NASDAQ), 48.76%
iSpecimen Inc. (ISPC:NASDAQ), 47.73%
Zenta Group Company Limited (ZGM:NASDAQ), 47.65%
Entero Therapeutics, Inc. (ENTO:NASDAQ), 36.96%